Khan, Muhammad Suleman <br/><br/>
Pharmacogenetics, plasma concentrations, clinical signs and EEG during propofol treatment.  [electronic resource] 

 -  Basic & clinical pharmacology & toxicology  Dec 2014 
 - 565-70 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1742-7843 
<br/><br/><label>Standard No.: </label>10.1111/bcpt.12277  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anesthetics, Intravenous--blood<br/>Cytochrome P-450 CYP2B6--genetics<br/>Cytochrome P-450 CYP2C9--genetics<br/>Electroencephalography--drug effects<br/>Female<br/>Genotype<br/>Glucuronosyltransferase--genetics<br/>Humans<br/>Male<br/>Polymorphism, Genetic<br/>Propofol--blood<br/>Receptors, GABA-A--genetics<br/>UDP-Glucuronosyltransferase 1A9